ADVERTISEMENT

Cover Story

Factoring in Face Time
Adam Kucharski | Jun 1, 2013 | 10+ min read
How the study of human social interactions is helping researchers understand the spread of diseases like influenza and HIV
Models of Transparency
Joan K. Heath, Richard White, Kirsten C. Sadler, and David Langenau | Apr 1, 2013 | 10+ min read
Researchers are taking advantage of small, transparent zebrafish embryos and larvae—and a special strain of see-through adults—to understand the development and spread of cancer.
Color from Structure
Cristina Luiggi | Feb 1, 2013 | 10+ min read
Researchers are working to understand how often-colorless biological nanostructures give rise to some of the most spectacular technicolor displays in nature.
Games for Science
The Scientist | Jan 1, 2013 | 10+ min read
Scientists are using video games to tap the collective intelligence of people around the world, while doctors and educators are turning to games to treat and teach.
Fat's Immune Sentinels
Justin Odegaard and Ajay Chawla | Dec 1, 2012 | 10 min read
Certain immune cells keep adipose tissue in check by helping to define normal and abnormal physiological states.
Coming to Terms
Anna Ajduk and Magdalena Zernicka-Goetz | Nov 1, 2012 | 10+ min read
New noninvasive methods of selecting the most viable embryo could revolutionize in vitro fertilization.
Lamarck and the Missing Lnc
Kevin V. Morris | Oct 1, 2012 | 8 min read
Epigenetic changes accrued over an organism’s lifetime may leave a permanent heritable mark on the genome, through the help of long noncoding RNAs.
Celebrating 25 Years of The Scientist
The Scientist Staff | Oct 1, 2011 | 1 min read
Our silver anniversary issue celebrates a quarter century of covering major advances in the life sciences—some in fields that didn’t even exist when we first went to press—and looks ahead to future research milestones.
Vaccines
Robin A. Weiss and Peter Hale | Jun 1, 2011 | 4 min read
Looking back, looking ahead
Taking Aim at Melanoma
Keith T. Flaherty | Apr 1, 2011 | 10+ min read
Understanding oncogenesis at the molecular level offers the prospect of tailoring treatments much more precisely for patients with advanced cases of this deadliest of skin cancers.
Epigenetic Changes in Cancer
Manel Esteller | Mar 1, 2011 | 10+ min read
The study of how covalent marks on DNA and histones are involved in the origin and spread of cancer cells is also leading to new therapeutic strategies.
ADVERTISEMENT